Abstract

Objective To construct conditionally replicative adenovirus (CRAds) expressing proliferation cell nuclear antigen (Ki-67) siRNA and human telomerase reverse transcriptase (hTERT) siRNA with Ki-67 promoter regulation.Methods (1) The hTERT siRNA sequence was synthesized and cloned into pSilencer3.1,resulting in the plasmid pShTERT siRNA.(2) Both pZKi-67 and pZD55-Ki-67 siRNA plasmid were digested with Xba I/EcoRV,the fragment containing Ki-67 promoter and the fragment containing Ki-67siRNA were connected,resulting in the plasmid pZKi-67-ZD-Ki-67siRNA.(3) The hTERTsiRNA was amplified from pShTERT siRNA and cloned into pZKi-67-ZD-Ki-67siRNA,resulting in the plasmid pZKi-67-ZD-Ki-67siRNA-hTERT siRNA.(4) pZKi-67-ZD-Ki-67 siRNA-hTERT siRNA was mixed with adenovirus packaging plasmid pBHGE3 and then co-transfected into HEK293 cells.The viral plaques appeared 9-12 days after infection.To verify the sequences of ZKi-67-ZD-Ki-67siRNA-hTERTsiRNA,DNA was extracted from purified viruses and analysed by polymerase chain reaction (PCR).Results Confirmed by PCR assay and sequence assay,a dual-RNA interferenced oncolytic adenovirus,which carried the Ki-67-siRNA and hTERT-siRNA and synchronously was regulated by both Ki-67 promoter was constructed.Conclusion We successfully constructed a dual-RNA interferenced oncolytic adenovirus and provide a new platform for cancer gene therapy. Key words: Conditionally replicative adenovirus; Proliferation cell nuclear antigen promoter; Proliferation cell nuclear antigen; Human telomerase reverse transcriptase; RNA interference

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.